tradingkey.logo

Globus Medical Inc

GMED

52.640USD

+0.010+0.02%
Close 08/01, 16:00ETQuotes delayed by 15 min
7.13BMarket Cap
38.40P/E TTM

Globus Medical Inc

52.640

+0.010+0.02%
More Details of Globus Medical Inc Company
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
Ticker SymbolGMED
Company nameGlobus Medical Inc
IPO dateMar 08, 2012
Founded at2003
CEOMr. Keith W. Pfeil
Number of employees5300
Security typeOrdinary Share
Fiscal year-endMar 08
Address2560 General Armistead Ave
CityAUDUBON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code19403
Phone16109301800
Websitehttps://www.globusmedical.com/
Ticker SymbolGMED
IPO dateMar 08, 2012
Founded at2003
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
By RegionUSD
Name
Revenue
Proportion
United States
483.86M
80.90%
International
114.26M
19.10%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.64%
BlackRock Institutional Trust Company, N.A.
8.73%
Janus Henderson Investors
6.20%
State Street Global Advisors (US)
3.20%
Burgundy Asset Management Ltd.
2.48%
Other
69.75%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.64%
BlackRock Institutional Trust Company, N.A.
8.73%
Janus Henderson Investors
6.20%
State Street Global Advisors (US)
3.20%
Burgundy Asset Management Ltd.
2.48%
Other
69.75%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.38%
Investment Advisor/Hedge Fund
35.54%
Hedge Fund
8.07%
Pension Fund
2.05%
Sovereign Wealth Fund
1.30%
Research Firm
1.26%
Bank and Trust
0.74%
Individual Investor
0.69%
Venture Capital
0.16%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1028
114.22M
101.13%
-12.77M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
10.88M
9.64%
+45.25K
+0.42%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.87M
8.73%
+23.63K
+0.24%
Mar 31, 2025
Janus Henderson Investors
7.01M
6.2%
+391.41K
+5.92%
Mar 31, 2025
State Street Global Advisors (US)
3.62M
3.2%
+21.05K
+0.59%
Mar 31, 2025
Burgundy Asset Management Ltd.
2.80M
2.48%
+183.64K
+7.01%
Mar 31, 2025
JP Morgan Asset Management
2.45M
2.17%
-176.33K
-6.72%
Mar 31, 2025
William Blair Investment Management, LLC
2.27M
2.01%
+1.04M
+84.46%
Mar 31, 2025
Sculptor Capital Management, Inc
2.09M
1.85%
+15.00K
+0.72%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.03M
1.8%
+135.02K
+7.12%
Mar 31, 2025
Wellington Management Company, LLP
1.88M
1.67%
-614.18K
-24.60%
Mar 31, 2025
View more
Related ETFs
Updated: 3 minutes ago
Updated: 3 minutes ago
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
2.86%
Motley Fool Small-Cap Growth ETF
2.42%
SPDR S&P Health Care Equipment ETF
1.77%
ERShares Entrepreneurs ETF
1.54%
First Trust Indxx Medical Devices ETF
1.51%
Invesco S&P MidCap 400 Pure Growth ETF
1.38%
ROBO Global Healthcare Technology & Innovation ETF
1.26%
Global X Guru Index ETF
1.17%
ROBO Global Robotics and Automation Index ETF
1.15%
Pacer US Cash Cows Growth ETF
1.06%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.86%
Motley Fool Small-Cap Growth ETF
Proportion2.42%
SPDR S&P Health Care Equipment ETF
Proportion1.77%
ERShares Entrepreneurs ETF
Proportion1.54%
First Trust Indxx Medical Devices ETF
Proportion1.51%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion1.38%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.26%
Global X Guru Index ETF
Proportion1.17%
ROBO Global Robotics and Automation Index ETF
Proportion1.15%
Pacer US Cash Cows Growth ETF
Proportion1.06%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI